Lung cancer, Small cell lung cancer
Results
Phase 1
This trial looked at a drug called everolimus in combination with cisplatin and etoposide chemotherapy for small cell lung cancer that has spread.
Recruitment start: 26 April 2007
Recruitment end: 30 November 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Peter Schmid
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 12 August 2014
CRUK internal database number: 1591